Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
36
Number of overlapping holdings
9.1%
% of FHLC's 405 holdings also in XPH
97.3%
% of XPH's 40 holdings also in FHLC
Overlap by Weight
Sector Drift (FHLC minus XPH)
Overlapping Holdings
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in FHLC |
Weight in XPH |
Overlap | |
|---|---|---|---|---|
 |
ELI LILLY & CO | 8.2% | 5.6% | 5.6% |
|
MERCK & CO. INC. | 4.8% | 4.2% | 4.2% |
|
JOHNSON & JOHNSON | 6.9% | 4.0% | 4.0% |
|
PFIZER INC | 3.4% | 3.8% | 3.4% |
|
BRISTOL-MYERS SQUIBB CO | 2.2% | 3.9% | 2.2% |
Position Highlights (Non-Overlapping Exposures)
FHLC Overweight Relative to XPH
|
UNITEDHEALTH GROUP INC | 8.0% |
|
ABBVIE INC | 4.8% |
|
THERMO FISHER SCIENTIFIC INC | 3.5% |
|
DANAHER CORP | 3.2% |
|
ABBOTT LABORATORIES | 3.1% |
|
JOHNSON & JOHNSON | 2.9% |
|
ELI LILLY & CO | 2.7% |
|
AMGEN INC | 2.5% |
 |
MEDTRONIC PLC | 1.9% |
|
ANTHEM INC | 1.9% |
FHLC Underweight Relative to XPH
|
REATA PHARMACEUTICALS, INC. CLASS A | -7.8% |
|
ELANCO ANIMAL HEALTH, INC. | -5.6% |
|
CATALENT INC | -5.3% |
|
AXSOME THERAPEUTICS, INC. | -4.4% |
|
JAZZ PHARMACEUTICALS PLC | -4.3% |
|
VIATRIS, INC. | -4.3% |
|
ORGANON & CO. | -3.8% |
|
PERRIGO CO | -3.6% |
|
INTRA-CELLULAR THERAPIES INC | -3.5% |
|
ROYALTY PHARMA PLC CLASS A | -3.5% |